AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtino M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biovensia Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimtino M 1mg/500mg Tablet SR

DiaBeta Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiaBeta Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Commonly, DiaBeta Duo can cause hypoglycemia (low blood sugar). Learn to identify symptoms such as tremors, sweating, dizziness, and headaches, and know how to treat them. Maintain regular mealtimes and carry a fast-acting glucose source like candy or juice. Alcohol consumption should be limited due to its hypoglycemic effect. Additional potential side effects include nausea, diarrhea, abdominal discomfort, altered taste perception, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting treatment. Pregnant or lactating women must consult their doctor. Regular blood glucose monitoring is essential, along with potential blood tests to assess hematologic parameters and liver function.

Primary Ingredients of Glimtino M 1mg/500mg Tablet SR

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Glimtino M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimtino M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtino M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Glimtino M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtino M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimtino M 1mg/500mg SR Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glimtino M 1mg/500mg Tablet SR works:

Glimtino M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimtino M 1mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimtino M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Glimtino M 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtino M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimtino M 1mg/500mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimtino M 1mg/500mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Medical advice is recommended. For patients experiencing mild to moderate liver disease, initiate treatment with a reduced Glimtino M 1mg/500mg SR tablet dosage; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimtino M 1mg/500mg Tablet SR :

Should you forget a Glimtino M 1mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtino M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimtino M 1mg/500mg Tablet SR

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Glimtino M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms occur, discontinue Glimtino M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimtino M 1mg/500mg Extended-Release tablets contain glimepiride and metformin. This dual-action medication manages type 2 diabetes mellitus in adults, enhancing glycemic control when coupled with a healthy diet and physical activity. Glimepiride's mechanism involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimtino M 1mg/500mg SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged use of Glimtino M 1mg/500mg Tablet SR can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, as proposed by some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glimtino M 1mg/500mg Sustained-Release Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimtino M 1mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimtino M 1mg/500mg Tabl...
37
MRP 45
17% off